191 related articles for article (PubMed ID: 26517370)
1. Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis.
Yuan F; Cheng Q; Li G; Tong T
PLoS One; 2015; 10(10):e0141678. PubMed ID: 26517370
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
Hua L; Hu B; Yan D; Liu J; Shen Y; Zhao F; Shen C; Chen B; Cui X
Pathol Res Pract; 2017 Jun; 213(6):688-697. PubMed ID: 28476378
[TBL] [Abstract][Full Text] [Related]
3. Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress.
Wang J; McGrail DJ; Bhupal PK; Zhang W; Lin KY; Ku YH; Lin T; Wu H; Tsai KC; Li K; Peng CY; Finegold MJ; Lin SY; Tsai RYL
Mol Cancer Res; 2020 May; 18(5):723-734. PubMed ID: 32051231
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
5. Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.
Nakanishi Y; Shiraha H; Nishina S; Tanaka S; Matsubara M; Horiguchi S; Iwamuro M; Takaoka N; Uemura M; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yagi T; Yamamoto K
BMC Cancer; 2011 Jan; 11():3. PubMed ID: 21205319
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
7. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
8. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
Zhang D; Liu J; Wang Y; Chen J; Chen T
J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
[TBL] [Abstract][Full Text] [Related]
9. Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27
Hu B; Hua L; Ni W; Wu M; Yan D; Chen Y; Lu C; Chen B; Wan C
Cancer Lett; 2017 Mar; 388():220-229. PubMed ID: 27998760
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma.
Zhou H; Bao J; Zhu X; Dai G; Jiang X; Jiao X; Sheng H; Huang J; Yu H
Biomed Res Int; 2018; 2018():1073432. PubMed ID: 30533424
[TBL] [Abstract][Full Text] [Related]
12. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
Li J; Gao JZ; Du JL; Huang ZX; Wei LX
Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
[TBL] [Abstract][Full Text] [Related]
13. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
15. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinoma.
Wen J; Xu J; Sun Q; Xing C; Yin W
Mol Med Rep; 2016 May; 13(5):4481-6. PubMed ID: 27035680
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
Cheng Q; Cao X; Yuan F; Li G; Tong T
Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma.
Cheng S; Luo M; Ding C; Peng C; Lv Z; Tong R; Xiao H; Xie H; Zhou L; Wu J; Zheng S
Gene; 2016 Oct; 591(1):236-244. PubMed ID: 27397650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]